PRODUCT DESCRIPTION:
NATtrol MERS-S. cerevisiae Recombinant (NATCOV(MR)-BIO) is with purified, intact yeast cells that have been chemically modified to render them non-infectious and refrigerator stable. Each vial contains 0.6 mL of NATtrol Middle East Respiratory Syndrome-Coronavirus recombinant sequence in S. cerevisiae; the MERS specific sequence is less than 500 bp and represents a small, non-infectious portion of the virus. NATCOV(MR)-BIO is supplied in a purified protein matrix that mimics the composition of a true clinical specimen.
INTENDED USE:
NATtrol MERS-S. cerevisiae is Recombinant designed to evaluate the performance of nucleic acid tests for determination of the presence of MERS-Coronavirus RNA. NATCOV(MR)-BIO can also be used for validation of clinical assays, development of diagnostic tests and training of laboratory personnel. NATCOV(MR)-BIO contains intact yeast cells and should be run in a manner identical to that used for clinical specimens.
ETIOLOGIC STATUS/BIOHAZARD TESTING:
NATtrol inactivation was carried out on the MERS-S. cerevisiae Recombinant stock used to formulate this product. The inactivation was verified by the absence of growth in validated tissue culture based infectivity assays and growth
protocols. Purified protein matrix used in the manufacture of this product is treated with 0.09% sodium azide.
It was manufactured from materials that have been tested and found non-reactive at the donor level for HIV-1/HIV-2 Antibody, HBsAg and HCV Antibody by FDA licensed donor screening test methods. All materials are also tested for HIV-1 and HCV by FDA approved Nucleic Acid Test (NAT) methods. Heat inactivated bovine based source materials used in the manufacture of this product meet applicable USDA requirements for abattoir sourced animals, traceability and country of origin. The materials were collected at USDA licensed establishments or legally imported from countries recognized by the USDA as negligible or controlled for risk for Bovine Spongiform Encephalopathy (BSE) and other exotic disease agents. Donor animals were inspected ante and post mortem at the abattoir as required by the USDA.
NATtrol MERS Recombinant Pack NATMR-BIO
Product Description:
NATtrol MERS Recombinant Pack (NATMR-BIO)* is formulated with pure, intact yeast cells that have been chemically modified to be non-infectious and refrigerator stable. 1 x 0.2mL vial of NATtrol™ Middle East Respiratory Syndrome-Coronavirus Recombinant Sequence 1 in S. cerevisiae in NATMR-BIO, 1 x 0.2mL Vial of NATtrol™ Middle East Respiratory Syndrome-Coronavirus Recombinant Sequence 2 in S. cerevisiae, and 1 x 0.5mL vial of negative control; MERS specific sequences are shorter than 500 bp and represent short, non-infectious parts of the virus. NATMR-BIO is supplied in a purified protein matrix that mimics the structure of a true clinical sample.
NATtrol MERS-CoV Stock (Qualitative) (1 mL) |
|||
| NATMERS-ST | Zeptometrix | 1 mL | 612 EUR |
Recombinant S. cerevisiae TIM14 |
|||
| CR26-10ug | Novoprotein | 10ug | 242.4 EUR |
Recombinant S. cerevisiae TIM14 |
|||
| CR26-1mg | Novoprotein | 1mg | 2983.2 EUR |
Recombinant S. cerevisiae TIM14 |
|||
| CR26-500ug | Novoprotein | 500ug | 1935.6 EUR |
Recombinant S. cerevisiae TIM14 |
|||
| CR26-50ug | Novoprotein | 50ug | 595.2 EUR |
ATP Sulfurylase, S. cerevisiae Recombinant |
|||
| P1542-100 | Biovision | 100 µg | 1548 EUR |
ATP Sulfurylase, S. cerevisiae Recombinant |
|||
| P1542-20 | Biovision | 20 µg | 429.6 EUR |
Recombinant Human COX17 (S. cerevisiae) |
|||
| COX17-448H | Creative BioMart | 200ug | 398.4 EUR |
Recombinant S. Cerevisiae TIM16 Protein |
|||
| MBS2557614-001mg | MyBiosource | 0.01mg | 220 EUR |
Recombinant S. Cerevisiae TIM16 Protein |
|||
| MBS2557614-005mg | MyBiosource | 0.05mg | 505 EUR |
Recombinant S. Cerevisiae TIM16 Protein |
|||
| MBS2557614-5x005mg | MyBiosource | 5x0.05mg | 2270 EUR |
Recombinant S. Cerevisiae TIM14 Protein |
|||
| MBS2557615-001mg | MyBiosource | 0.01mg | 220 EUR |
Recombinant S. Cerevisiae TIM14 Protein |
|||
| MBS2557615-005mg | MyBiosource | 0.05mg | 505 EUR |
Recombinant S. Cerevisiae TIM14 Protein |
|||
| MBS2557615-5x005mg | MyBiosource | 5x0.05mg | 2270 EUR |
Intended use:
The NATtrol MERS Recombinant Pack is designed to evaluate the performance of nucleic acid tests for the determination of the presence of MERS-Coronavirus RNA. NATMR-BIO can also be used for validation of clinical assays, development of diagnostic tests and training of laboratory personnel.
NATMR-BIO contains intact yeast cells and should be run in a manner identical to that used for clinical specimens.
